Ahead of the International Vitiligo Day, a herbal drug developed by the Defence Research and Development Organisation (DRDO) has given a new hope to those suffering from leucoderma, a skin condition in which white patches develop on the skin.
Recognising the benefits of the drug, the Narendra Modi government last month conferred Hemant Pandey, a senior DRDO scientist with the prestigious "Science Award" for developing 'lukoskin' for treating the skin condition mired by social stigma.
The auto-immune condition, also called 'vitiligo', can be life-altering.
Some people develop low self-esteem and severe depression, an observation which prompted Pandey to work on an advanced version of Lukoskin drug for better results.
As the world marks June 25 as International Vitiligo Day, Pandey, who heads the Herbal Medicine Division of DRDO's Defence Institute of Bio-energy Research (DIBER) at Pithoragarh, talked about Lukoskin, which is presently manufactured and marketed by Delhi-based AIMIL Pharma Ltd.